The article discusses statistical data on life sciences venture investments including the percentage of internal rate of return (IRR) by sector for realized and unrealized deals, healthcare investing venture and technology, the percentage of distribution of investment multiple, percentage rate of loss and percentage return since initial public offering (IPO).